Coya Therapeutics (COYA) Preferred Shares (2021 - 2022)
Coya Therapeutics (COYA) reported Preferred Shares of $8.8 million for Q4 2022, little changed on a YoY basis from $8.8 million in Q4 2021, and little changed sequentially from $8.8 million in Q4 2021.
Coya Therapeutics (COYA) Preferred Shares (2021 - 2022) Analysis & Trends
Coya Therapeutics (COYA) has 2 years of Preferred Shares data on file, last reported at $8.8 million in Q4 2022.
- For the quarter ending Q4 2022, Preferred Shares changed 0.0% year-over-year to $8.8 million; the trailing twelve-month figure through Dec 2022 stood at $8.8 million (changed 0.0% YoY), and the FY2022 full-year result was $8.8 million, changed 0.0% from the prior year.
- Preferred Shares steadied at $8.8 million in Q4 2022, from $8.8 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $8.8 million in Q4 2021 to a low of $8.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | - |
| 10 | Coya Therapeutics | 97.82 Mn | 47.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8.79 Mn |
| Dec 31, 2021 | 8.79 Mn |